Detalhe da pesquisa
1.
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
Br J Haematol
; 166(1): 69-76, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24673512